ORIGINAL RESEARCH article
Front. Oncol.
Sec. Breast Cancer
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1619346
This article is part of the Research TopicEpigenetic and Metabolic Regulators of Breast Carcinogenesis Volume IIView all articles
Progress in Epigenetic Research of Breast Cancer: A Bibliometric Analysis Since the 2000s
Provisionally accepted
- 1The First Clinical College of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China
- 2The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China
- 3Medical College, Hunan University of Chinese Medicine, Changsha, Anhui Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Breast cancer continues to be a leading cause of cancer-related deaths among women worldwide. Despite advancements in diagnostics and therapies, challenges such as metastasis, recurrence, and resistance remain prevalent. Recently, research has shifted from traditional genomic analyses to the study of epigenetic regulation, which includes DNA methylation, histone modifications, and non-coding RNAs. Given the rapid expansion of literature in this field, a systematic overview of its evolution and emerging trends is necessary. Methods: We performed a comprehensive bibliometric analysis of 5,271 articles on breast cancer epigenetics, sourced from the Web of Science Core Collection, covering the years 2000 to 2024. Utilizing tools like CiteSpace and VOSviewer, with support from RStudio, Pajek, and HisCite, we analyzed co-citation networks, keyword co-occurrence, and burst detection. This analysis included visualizations of collaboration among authors, institutions, and countries. Metrics such as modularity, silhouette scores, and betweenness centrality were used to ensure analytical rigor and to identify thematic evolution and emerging research frontiers. Results: From 2000 to 2018, the number of annual publications increased steadily, with citation peaks occurring in 2021. The United States led in research output and influence, followed by China. Leading institutions included Johns Hopkins University and the University of Texas MD Anderson Cancer Center. Keyword and co-citation analyses revealed four research phases: (1) early studies focused on promoter hypermethylation of tumor suppressor genes like RASSF1A; (2) an in-depth investigation of molecular mechanisms, including epithelial-mesenchymal transition and chromatin remodeling; (3) translational research involving HDAC inhibitors and DNA methylation biomarkers; and (4) recent advancements in multi-omics integration, synthetic lethality, and the study of epigenetics in the tumor microenvironment. Emerging research directions include the targeted removal of epigenetic memory, metabolism-epigenetics networks, and single-cell epigenomic profiling. Conclusion: This bibliometric study outlines the trajectory of research in breast cancer epigenetics, highlighting its evolution from basic methylation studies to advanced therapeutic exploration. Future research should focus on targeting epigenetic memory to combat drug resistance and recurrence, developing synthetic lethality strategies, and employing single-cell technologies for dynamic epigenetic mapping. These findings provide a strategic roadmap for researchers and policymakers navigating the evolving landscape of breast cancer epigenetics.
Keywords: Bibliometric Study, epigenetics, breast cancer, visualization, Bibliometric, Citespace, VOSviewer
Received: 28 Apr 2025; Accepted: 21 Aug 2025.
Copyright: © 2025 Yang, Fang, Wang, Lu, Chen and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hui Liu, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.